Skip to content
healthcare.dev

Acne Buster Salicylic Acid Drying Serum

NDC 84509-102, ZINC OXIDE,NIACINAMIDE,COLLOIDAL SULFUR,AZELAIC ACID,SALICYLIC ACID., liquid, from Guangzhou Senmai Biotechnology Co.,Ltd..

Product NDC
84509-102
Status
Listed
Labeler
Guangzhou Senmai Biotechnology Co.,Ltd.
Dosage form
LIQUID
Route
TOPICAL
Product type
HUMAN OTC DRUG
Marketing category
OTC MONOGRAPH DRUG
Application
M016
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/84509-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • SALICYLIC ACID.018 mg/10mL
  • NIACINAMIDE.05 mg/10mL
  • AZELAIC ACID.024 mg/10mL
  • SULFUR.03 mg/10mL
  • ZINC OXIDE.2 mg/10mL

Pharmacologic classes

Decreased Protein Synthesis [PE]; Decreased Sebaceous Gland Activity [PE]

Package NDCNDC-11Package
84509-102-018450901020110 mL in 1 BOTTLE (84509-102-01)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 84509-102 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/84509-102 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 84509-102. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.